212Pb-TCMC-Trastuzumab

lead-212 labeled trastuzumab radioimmunotherapy · Orano Med LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 212Pb-TCMC-Trastuzumab, covering 2016-09-30 to 2016-09-30. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy [Phase 1]